<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><description>聚焦生物医药前沿，洞察研发投资风向</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 31 May 2021 23:37:44 +0800</pubDate><image><url>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</url><title>医药魔方Pro | wechat-feeds</title><link>http://MzU1MTk1NTUwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>阿尔茨海默症疗法新进展！靶向PAC1R：精确清除有毒tau蛋白，改善小鼠认知能力 | Science子刊</title><link>https://mp.weixin.qq.com/s/1PC6stMvW-9ay1S_RYe64w</link><description></description><content:encoded><![CDATA[阿尔茨海默症疗法新进展！靶向PAC1R：精确清除有毒tau蛋白，改善小鼠认知能力 | Science子刊]]></content:encoded><pubDate>Mon, 31 May 2021 21:00:11 +0800</pubDate></item><item><title>Science子刊报道前列腺癌新疗法：恩扎卢胺“搭档”H6PD抑制剂，显著改善小鼠生存</title><link>https://mp.weixin.qq.com/s/iXw9Bb-ZpDAQmKSnTlOX_A</link><description></description><content:encoded><![CDATA[Science子刊报道前列腺癌新疗法：恩扎卢胺“搭档”H6PD抑制剂，显著改善小鼠生存]]></content:encoded><pubDate>Sun, 30 May 2021 21:00:05 +0800</pubDate></item><item><title>主攻实体瘤细胞疗法！这家“年轻却资深”的公司IPO拟募资1.5亿美元，重点产品靶向ROR-1</title><link>https://mp.weixin.qq.com/s/rwuAK0klHmua9Rltbl7UZw</link><description></description><content:encoded><![CDATA[主攻实体瘤细胞疗法！这家“年轻却资深”的公司IPO拟募资1.5亿美元，重点产品靶向ROR-1]]></content:encoded><pubDate>Sat, 29 May 2021 20:58:47 +0800</pubDate></item><item><title>CRISPR、iPSC两大诺奖技术联手！现货型CAR iPS-T细胞疗法来了 | Nature子刊</title><link>https://mp.weixin.qq.com/s/ArkUV-PyKwvWymRy8qZQbg</link><description></description><content:encoded><![CDATA[CRISPR、iPSC两大诺奖技术联手！现货型CAR iPS-T细胞疗法来了 | Nature子刊]]></content:encoded><pubDate>Fri, 28 May 2021 20:58:24 +0800</pubDate></item><item><title>2021Q1全球生物医药融资版图：总额超169亿美元、24家公司IPO、细胞疗法百花齐放</title><link>https://mp.weixin.qq.com/s/-kKfUBhbqSGlPdK3b5WGdw</link><description></description><content:encoded><![CDATA[2021Q1全球生物医药融资版图：总额超169亿美元、24家公司IPO、细胞疗法百花齐放]]></content:encoded><pubDate>Thu, 27 May 2021 20:59:41 +0800</pubDate></item><item><title>75％的小鼠肿瘤完全缓解！新型癌症疫苗让免疫检查点抑制剂更有效 | Nature子刊</title><link>https://mp.weixin.qq.com/s/jBjpHcZdr_eI2VrUSofRfw</link><description></description><content:encoded><![CDATA[75％的小鼠肿瘤完全缓解！新型癌症疫苗让免疫检查点抑制剂更有效 | Nature子刊]]></content:encoded><pubDate>Wed, 26 May 2021 21:01:55 +0800</pubDate></item><item><title>双抗ADC、突破性疗法：非天然氨基酸抗体偶联技术解析</title><link>https://mp.weixin.qq.com/s/cpDt4MKyjDMW4lYynTA4xQ</link><description></description><content:encoded><![CDATA[双抗ADC、突破性疗法：非天然氨基酸抗体偶联技术解析]]></content:encoded><pubDate>Tue, 25 May 2021 21:00:46 +0800</pubDate></item><item><title>郑彪点评 | Science突破：新型CAR-T有效杀伤实体瘤，不伤正常细胞</title><link>https://mp.weixin.qq.com/s/3IDfAXJgrBhfzRYAkTTjJw</link><description></description><content:encoded><![CDATA[郑彪点评 | Science突破：新型CAR-T有效杀伤实体瘤，不伤正常细胞]]></content:encoded><pubDate>Mon, 24 May 2021 21:24:38 +0800</pubDate></item><item><title>脂肪肝新靶点——ABCB10 | Science子刊最新成果</title><link>https://mp.weixin.qq.com/s/1gpl5i1jZRtbkg0w6d9Rxg</link><description></description><content:encoded><![CDATA[脂肪肝新靶点——ABCB10 | Science子刊最新成果]]></content:encoded><pubDate>Sun, 23 May 2021 21:00:54 +0800</pubDate></item><item><title>ASCO2021摘要精选50篇（KRAS抑制剂、Her2 ADC、TROP2 ADC……）</title><link>https://mp.weixin.qq.com/s/G6KNXF-PilLkkXP0_8O_Rg</link><description></description><content:encoded><![CDATA[ASCO2021摘要精选50篇（KRAS抑制剂、Her2 ADC、TROP2 ADC……）]]></content:encoded><pubDate>Sat, 22 May 2021 20:58:34 +0800</pubDate></item></channel></rss>